Pro Share Advisors LLC Unity Biotechnology, Inc. Transaction History

Pro Share Advisors LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$1.3 - $3.17 $15,303 - $37,317	-11,772 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$2.91 - $4.5 $34,256 - $52,974	11,772 New	11,772 $35,000
Q2 2021 Aug 13, 2021	SELL	$4.15 - $6.3 $69,620 - $105,688	-16,776 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$5.51 - $9.42 $4,187 - $7,159	760 Added 4.75%	16,776 $101,000
Q4 2020 Feb 09, 2021	BUY	$3.42 - $6.36 $11,487 - $21,363	3,359 Added 26.54%	16,016 $84,000
Q3 2020 Nov 13, 2020	BUY	$2.94 - $12.43 $979 - $4,139	333 Added 2.7%	12,657 $44,000
Q2 2020 Aug 03, 2020	BUY	$5.28 - $9.67 $65,070 - $119,173	12,324 New	12,324 $107,000
Q1 2020 May 15, 2020	SELL	$5.0 - $7.6 $69,110 - $105,047	-13,822 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$5.99 - $8.38 $5,468 - $7,650	-913 Reduced 6.2%	13,822 $100,000
Q3 2019 Nov 12, 2019	SELL	$5.62 - $9.63 $2,410 - $4,131	-429 Reduced 2.83%	14,735 $90,000
Q2 2019 Aug 13, 2019	SELL	$7.59 - $10.21 $14,565 - $19,592	-1,919 Reduced 11.23%	15,164 $144,000
Q1 2019 May 15, 2019	BUY	$7.65 - $16.66 $895 - $1,949	117 Added 0.69%	17,083 $139,000
Q4 2018 Feb 14, 2019	BUY	$10.76 - $17.25 $182,554 - $292,663	16,966 New	16,966 $276,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $14M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.